Development of Homogeneous 384-Well High-Throughput Screening Assays for Aβ1-40 and Aβ1-42 Using AlphaScreen™ Technology

This publication has 12 references indexed in Scilit:

• Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms
  Journal of Neurochemistry, 2006
• Amino-Truncated β-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive Impairment
  Clinical Chemistry, 2005
• Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2 S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7 S)-5-methyl-6-oxo-6,7-dihydro-5 H-dibenzo[b,d]azepin-7-yl]-l-alaninamide]
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
  Nature Neuroscience, 2004
• Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay
  Journal of Neuroscience Methods, 2000
• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
  Nature Medicine, 2000
• L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity
  Biochemistry, 2000
• Modulation of amyloid precursor protein processing by compounds with various mechanisms of action: detection by liquid phase electrochemiluminescent system
  Journal of Neuroscience Methods, 1998
• Amyloid precursor protein processing and Aβ ₄₂ deposition in a transgenic mouse model of Alzheimer disease
  Proceedings of the National Academy of Sciences, 1997
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
  Nature, 1995